Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Pre-Tax Income
Formosa Laboratories Inc
Pre-Tax Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Pre-Tax Income
NT$410.7m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
19%
|
CAGR 10-Years
3%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Pre-Tax Income
NT$1.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Pre-Tax Income
NT$490.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-5%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Pre-Tax Income
NT$584.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-5%
|
CAGR 10-Years
6%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Pre-Tax Income
NT$5.4B
|
CAGR 3-Years
40%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Pre-Tax Income
NT$1.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
21%
|
CAGR 10-Years
14%
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Pre-Tax Income?
Pre-Tax Income
410.7m
TWD
Based on the financial report for Sep 30, 2024, Formosa Laboratories Inc's Pre-Tax Income amounts to 410.7m TWD.
What is Formosa Laboratories Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
3%
Over the last year, the Pre-Tax Income growth was 42%. The average annual Pre-Tax Income growth rates for Formosa Laboratories Inc have been -30% over the past three years , 19% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet